CDH1 and neoplasm: In this sense, upregulation of tumor cell ligands MICA/B for activating NKG2D receptor, upregulation of adhesion CADM1 molecule, and downmodulation of E-cadherin ligand for inhibitory KLRG4 receptor, favor the elimination of tumor cell undergoing EMT by NK cells.